your migraine daysChoose a dosing option that may be right for you IMPORTANT SAFETY INFORMATION Do not use AJOVY®if you are allergic to AJOVY or any of the ingredients in AJOVY. AJOVY may cause allergic reactions, including itching, rash, and hives that can happen within hours and up to...
Ajovy and Aimovig are both calcitonin gene-related peptide (CGRP) inhibitors used for migraine prevention in adults. The dosing, side effects, effectiveness and costs of these medicines can vary. As demonstrated in studies, these agents can reduce the number of migraine headache days you experienc...
• TwosubcutaneousdosingoptionsofAJOVYareavailableto injectionsitereactions.(6.1) administertherecommendeddosage: o 225mgmonthly,or ToreportSUSPECTEDADVERSEREACTIONS,contactTeva o 675mgevery3months(quarterly)(2.1) Pharmaceuticalsat1-orFDAat1-800-FDA-1088 ...
See how AJOVY could reduce your migraine days Choose a dosing option that may be right for you IMPORTANT SAFETY INFORMATION Do not use AJOVY® if you are allergic to AJOVY or any of the ingredients in AJOVY. AJOVY may cause allergic reactions, including itching, rash, and hives that can ...
225 mg once monthly administered as one subcutaneous injection (monthly dosing), or 675 mg every three months (quarterly dosing), which is administered as three subcutaneous injections. AJOVY can be administered either by a healthcare professional or at hom...
Adherence, persistence, switching, and reinitiation were evaluated for patients who had dosing data. A gap of >45 days in the EHR was used to identify switching or reinitiation.Results: Overall, 987 patients prescribed AJOVY were included; 594 (60.2%) had episodic migraine and 393 (39.8%) ...
) acute medications, including triptans (19% and 23%), ergots (1% and 1%), nonsteroidal anti-inflammatory drugs (12% and 14%), and opioids (7% and 11%).Conclusions: This real-world study showed that comorbidities at baseline were comparable for patients with quarterly and monthly dosing....